U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H9N3O2.HNO3
Molecular Weight 194.146
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CREATINE NITRATE

SMILES

O[N+]([O-])=O.CN(CC(O)=O)C(N)=N

InChI

InChIKey=MBSCHHMCRIMBDZ-UHFFFAOYSA-N
InChI=1S/C4H9N3O2.HNO3/c1-7(4(5)6)2-3(8)9;2-1(3)4/h2H2,1H3,(H3,5,6)(H,8,9);(H,2,3,4)

HIDE SMILES / InChI

Molecular Formula HNO3
Molecular Weight 63.0128
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C4H9N3O2
Molecular Weight 131.1332
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Creatine is an amino acid that occurs in vertebrate tissues and in urine. It is synthesized mainly in the liver from three different amino acids: arginine, glycine, and methionine. In skeletal muscles, which store 95% of it, creatine generally occurs as phosphocreatine. The rest is stored in the brain, heart, and testes. Creatine functions as part of the cell's energy shuttle. It is excreted as creatinine in the urine.

Approval Year

PubMed

PubMed

TitleDatePubMed
Interstitial nephritis in a patient taking creatine.
1999 Mar 11
Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy.
2000 Jan
Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero.
2001 Feb
Deterioration in renal function associated with fibrate therapy.
2001 Jan
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
2001 Jan
Oxygen free radical generation in healthy blood donors and cardiac patients: the protective effect of allopurinol.
2001 Jan
Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury.
2001 Jan
Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
2001 Jan
Evaluation of the dystrophin-glycoprotein complex, alpha-actinin, dysferlin and calpain 3 in an autosomal recessive muscular dystrophy in Labrador retrievers.
2001 Jan
Pretreatment of human myocardium with adenosine.
2001 Jan
Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction.
2001 Jan
Q-wave evolution of a first acute myocardial infarction without significant ST segment elevation.
2001 Jan
Effect of abciximab on cardiac enzyme elevation after transluminal extraction atherectomy (TEC) in high-risk saphenous vein graft lesions: comparison with a historical control group.
2001 Jan
Role of exercise and ascorbate on plasma antioxidant capacity in thoroughbred race horses.
2001 Jan
Win, place, show: creatine consumption and the price of winning.
2001 Jan
Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies.
2001 Jan
Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.
2001 Jan 6
Dysarthria as the leading symptom of hypothyroidism.
2001 Jan-Feb
Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.
2001 Mar
An (1)H-MRS evaluation of the phosphocreatine/creatine pool (tCr) in human muscle.
2001 Mar
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:10:32 UTC 2023
Edited
by admin
on Fri Dec 15 17:10:32 UTC 2023
Record UNII
1XGV09LL9X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CREATINE NITRATE
Common Name English
GLYCINE, N-(AMINOIMINOMETHYL)-N-METHYL-, NITRATE (1:1)
Common Name English
CREATINE, COMPD. WITH HNO3
Common Name English
GLYCINE, N-(AMINOIMINOMETHYL)-N-METHYL-, MONONITRATE
Common Name English
Code System Code Type Description
PUBCHEM
25231507
Created by admin on Fri Dec 15 17:10:32 UTC 2023 , Edited by admin on Fri Dec 15 17:10:32 UTC 2023
PRIMARY
CAS
89695-59-0
Created by admin on Fri Dec 15 17:10:32 UTC 2023 , Edited by admin on Fri Dec 15 17:10:32 UTC 2023
PRIMARY
FDA UNII
1XGV09LL9X
Created by admin on Fri Dec 15 17:10:32 UTC 2023 , Edited by admin on Fri Dec 15 17:10:32 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY